VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
28,193
AK1,084
AL2,357
AR1,552
AS31
AZ7,318
CA28,113
CO5,391
CT3,688
DC679
DE742
FL15,245
FM3
GA6,071
GU48
HI1,016
IA2,291
ID1,259
IL9,099
IN13,937
KS2,303
KY3,047
LA2,084
MA6,618
MD5,716
ME1,479
MH5
MI8,186
MN5,591
MO4,444
MP10
MS1,192
MT1,264
NC7,310
ND661
NE1,480
NH1,554
NJ7,347
NM1,943
NV1,714
NY15,329
OH9,083
OK2,500
OR3,708
PA9,656
PR1,070
QM1
RI1,028
SC2,716
SD664
TN3,894
TX15,169
UT2,152
VA6,860
VI22
VT887
WA6,284
WI5,307
WV1,172
WY426
XB4
XL1
XV1

ID: 0973380
Sex: F
Age:
State: NC

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slight nausea; This is a spontaneous report from a contactable consumer (patient). A 78-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL3248), via an unspecified route of administration on the left arm, on 13Jan2021 at 10:15, at a single dose for Covid-19 immunization. Medical history included vertebral artery occlusion. The patient did not receive other vaccines in four weeks. Concomitant medications included metoprolol, amlodipine, tramadol, and hydrochlorothiazide. The patient previously took oxycodone hydrochloride;paracetamol (PERCOCET), acetylsalicylic acid;oxycodone hydrochloride (PERCODAN) and hydrocodone and experienced allergies. On 13Jan2021, at 11:30, the patient experienced slight nausea. The patient did not receive any treatment for the event. Outcome of the event was not recovered.

Other Meds: METOPROLOL; AMLODIPINE; TRAMADOL; HYDROCHLOROTHIAZIDE.

Current Illness:

ID: 0973381
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu-like symptoms with a loss sense of smell; flu-like symptoms with a loss sense of smell; This is a spontaneous report from a non-contactable consumer, reporting for herself. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 09Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient developed flu-like symptoms with a loss sense of smell and was wondering what she should do. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973382
Sex: F
Age:
State: SC

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tested positive for covid 19; Tested positive for covid 19; missed the second dose at the 21-day mark and wants to know if it is okay to get the vaccine a week later; This is a spontaneous report via a Pfizer-sponsored program, Pfizer First Connect from a contactable nurse. A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Reporter stated she tested positive for COVID 19 after receiving the COVID 19 vaccine. She missed the second dose at the 21-day mark and wants to know if it is okay to get the vaccine a week later. She got sick and was tested positive after the vaccine. She's about to take the 2nd dose and wondering if she still has to take it or not. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. The outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973383
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient wanted to know if it was possible to send the patient some medical information about the side effects of the vaccine and time of duration. The patient experienced headache on an unspecified date. The outcome of the event was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973384
Sex: F
Age:
State: TN

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: rash which gotten bigger on the chest/rash around the side it has gotten bigger and now she is having them in other areas/rash around the left side on the arm; Very tired/Tiredness; Itching; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 07Jan2021 in the left arm at single dose for COVID-19 immunization. Medical history included chronic obstructive pulmonary disease (COPD) which she uses a nebulizer for this. There were no concomitant medications. The patient previously received first dose of BNT162B2 (lot number: EJ1685) on 18Dec2020 in the right arm for COVID-19 immunization. The patient reported that she was very tired, tiredness started on the same day as she received the second dose of the vaccine on 07Jan2021. The patient also developed a rash which gotten bigger on the chest, a rash around the side it has gotten bigger and now she was having them in other areas 3 days later (10Jan2021). The patient further explained that it also developed rash around the left side on the arm. The patient was using Cortizone cream over the counter and it relieved itching (started in Jan2021) but it didn't totally take it away. She still felt tired today. The patient had no positive tests for COVID and no antibody test before the vaccine. She had no issues with vaccine in the past. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973385
Sex: F
Age:
State: TN

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever 101; moderate headache; tachycardia at rest; This is a spontaneous report from a contactable nurse reporting for herself. A 40-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EL1287, expiry date: not reported), via an unspecified route of administration, on 12Jan2021 04:15 PM at a single dose on the left arm for COVID-19 immunization. The patient was not pregnant. She received the vaccine at a workplace clinic. She had not received any other vaccines in four weeks. Medical history included arthritis. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL), multivitamin, and airborne immune supplement; these are the other medications she took in two weeks. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EL1284, expiry date: not reported), via an unspecified route of administration, on 23Dec2020 04:45 PM at a single dose on the left arm for COVID-19 immunization. On 13Jan2021 03:00 AM, within 12 hours of 2nd vaccine dose, the patient experienced fever 101, moderate headache, tachycardia at rest. The patient was not diagnosed with COVID prior to vaccination and had not tested for COVID post vaccination. The patient received no treatment for the reported adverse events. Outcome of the events was recovering.

Other Meds: TYLENOL.

Current Illness:

ID: 0973386
Sex: M
Age:
State: VT

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; Chills; Headache; Pain at injection site; poor appetite; fever; This is a spontaneous report from a non-contactable other healthcare professional (patient). A 53-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249), intramuscular (left arm) on 11Jan2021 (16:45) at single dose for Covid-19 immunization. The patient received the first dose of COVID 19 vaccine (BNT162B2, lot number: EL1284) on 21Dec2020 (05:00 PM) intramuscular (left arm) for Covid-19 immunization. The patient's medical history included diabetic and heart disease; no known allergies. The patient's concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced body aches, chills, headache, pain at injection site, poor appetite, and fever on 12Jan2021. There was no treatment received for the adverse events. The outcome of events was recovering. The patient has not been tested for COVID-19 since the vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0973387
Sex: M
Age:
State: GA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme fatigue; mild headache; lump and extreme tenderness at injection site; lump and extreme tenderness at injection site; This is a spontaneous report from a contactable other healthcare professional (patient). A 47-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142), via an unspecified route of administration (left arm) on 08Jan2021 (09:30 AM) at single dose for Covid-19 immunization. The patient received the first dose of Covid-19 vaccine (BNT162B2, lot number: unknown), via an unspecified route of administration left arm on 18Dec2020 (09:30 AM) at single dose for Covid-19 immunization. The patient's medical history was reported as none. There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme fatigue, mild headache, lump and extreme tenderness at injection site on 09Jan2021 (08:00 AM). There was no treatment received for the adverse event. The outcome of events was recovered on an unspecified date. The patient has not been tested for COVID-19 since the vaccination.

Other Meds:

Current Illness:

ID: 0973388
Sex: F
Age:
State:

Vax Date: 12/28/2020
Onset Date: 12/29/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph nodes.; This is a spontaneous report from a Non-contactable consumer. A 67-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EH9899) on 28Dec2020 at 01:15 p.m. via an unspecified route of administration, on left arm at single dose for COVID-19 immunization. Relevant medical history included allergy to penicillin. Concomitant medications were not reported. On 29Dec2020 the patient experienced swollen lymph nodes. At the time of the reporting the patient had not recovered from the event. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0973389
Sex: F
Age:
State: TN

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), via an unspecified route of administration, on 08Jan2021 at 10:00 AM, at single dose for COVID-19 immunisation. Vaccine location was left arm. Age at vaccination was 50-years-old. Facility type vaccine was public Health Clinic/Veterans Administration facility. No other vaccine was received in four weeks. Medical history included blood pressure high (HBP), Sjogren's syndrome, Raynauds. Concomitant medications included sambucus nigra (ELDERBERRY), fish oil, magnesium, vitamin NOS (MULTIVITAMIN). On 09Jan2011, the patient experienced fatigue and shortness of breath. No treatment was received for the event. Outcome was unknown.

Other Meds: ELDERBERRY [SAMBUCUS NIGRA]; FISH OIL; MAGNESIUM; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 0973390
Sex: M
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe stomach pain; vomiting; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age (reported as "77", unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown) dose number 1, via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient felt fine for the first 5 days after receiving the vaccine then he developed severe stomach pain and vomiting in Jan2021. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973391
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/11/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: weird taste in her mouth/oatmeal-y taste in mouth; nauseous; This is a spontaneous report from a non-contactable nurse. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she still was very nauseous and took ondansetron (ZOFRAN). Patient also reported having a weird taste in her mouth, not necessarily lost of taste, but an oatmeal-y taste in her mouth. The outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973392
Sex: F
Age:
State: IL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vaginal bleeding; This is a spontaneous report from a contactable nurse (patient) via Medical information team. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration in left arm on 08Jan2021 at single dose for COVID-19 immunization. The patient have family history of diabetes mellitus from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took Vitamin B12 [cyanocobalamin] and experienced allergy rash and levothyroxine for hypothyroidism for more than a year. The patient received the first dose of the vaccine on 08Jan2021 at 11:20 or 11:25AM and at around 3 PM, she had noticed some vaginal bleeding. She thought it was her period but it stopped during the night (she mentioned she worked that night). She asked if this was a side effect from the vaccine. It was light, like when a person's period was coming but it was a brownish color, not red. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment given to the patient for the event. The outcome of the event was recovered on 08Jan2021.

Other Meds:

Current Illness:

ID: 0973393
Sex: F
Age:
State: CA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Exceptionally dry eyes; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient). A 42-year-old female patient received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246, expiry date: unknown), via an unspecified route of administration in the left arm, on 12Jan2021 08:30, at single dose, for COVID-19 immunization, in the hospital. There were not medical history and concomitant medications. The patient has no known allergies and is not pregnant. The patient did not have COVID-19 prior to vaccination. The patient did not receive other vaccines in four weeks. The patient experienced exceptionally dry eyes on 12Jan2021 at 20:30. Treatment included saline eye drops. The patient was not tested for COVID-19 post vaccination. The outcome of the event was recovered in Jan2021.

Other Meds:

Current Illness:

ID: 0973394
Sex: M
Age:
State: PA

Vax Date: 12/28/2020
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The day after I received the vaccine, I got the common side effects, chills, loose stool, nausea. I also began having heartburn/indigestion.It has been 16 days since the first dose, and the loose stool and heartburn/indigestion remain; The day after I received the vaccine, I got the common side effects, chills, loose stool, nausea. I also began having heartburn/indigestion.It has been 16 days since the first dose, and the loose stool and heartburn/indigestion remain; The day after I received the vaccine, I got the common side effects, chills, loose stool, nausea. I also began having heartburn/indigestion.It has been 16 days since the first dose, and the loose stool and heartburn/indigestion remain; The day after I received the vaccine, I got the common side effects, chills, loose stool, nausea. I also began having heartburn/indigestion.It has been 16 days since the first dose, and the loose stool and heartburn/indigestion remain; This is a spontaneous report from a contactable healthcare professional (HCP [patient]). A 43-year-old male patient received first single dose of BNT162B2 (Pfizer, Solution for injection, lot number and exp date not reported), intramuscular (vaccine location: left arm) on 28Dec2020 for COVID-19 immunization. Facility type vaccine: Nursing Home/Senior Living Facility. Medical history included gastric sleeve and surgery. The patient had no known allergies. Patient did not have Covid prior vaccination. There was no other medical history. There were no concomitant medications. There were no other vaccine/s within four weeks. No other medications in two weeks. The day after patient received the vaccine, she got the common side effects on Jan2021: chills, loose stool, and nausea. She also began having heartburn/indigestion (Jan2021). It had been 16 days since the first dose, and the loose stool and heartburn/indigestion remain. Not sure if it's because of having the gastric sleeve done years ago, or not, as the surgery changed her metabolism and the like. No treatment was provided. Nasal Swab on 11Jan2021 was negative. The outcome of the events was not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973395
Sex: F
Age:
State: NC

Vax Date: 01/06/2021
Onset Date: 01/08/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hypertension; Elevated HR; resting HR is tachy staying over 100 bpm; This is a spontaneous report from a contactable healthcare professional (patient). A 30-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), intramuscular in left arm, on 06Jan2021 at 12:00, at a single dose, for COVID-19 immunization. The patient's medical history included penicillin allergy. The patient's concomitant medication included lisinopril. The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccines were administered in four weeks. On 08Jan2021 at 12 AM, the patient experienced hypertension and elevated heart rate (HR). Resting HR is tachycardic (reported as tachy) staying over 100 bpm. The adverse events resulted in doctor or other healthcare professional office or clinic visit. An additional medication was given as treatment to bring HR down. Post-vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the events.

Other Meds: LISINOPRIL.

Current Illness:

ID: 0973396
Sex: F
Age:
State:

Vax Date: 01/05/2021
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy; tachycardic; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient got dizzy and tachycardic on an unspecified date. The patient asked if she should get the second dose. Clinical outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973397
Sex: F
Age:
State: CA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little aching in the shoulder part; Little soreness in the muscle; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from Jan2021 to Jan2021 at a single dose for COVID-19 immunization. Medical history included pain in her leg from a surgery; she said that she was taking Tylenol for it. It was reported that the patient just took the first dose of Covid 19 Vaccine yesterday and felt a little aching in the shoulder part, also Little soreness in the muscle; she wants to know as well if it's fine to take her daily medication Tylenol. She said that it is a little soreness in the muscle. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973398
Sex: F
Age:
State: NM

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Body aches; Fevers; This is a spontaneous report from a contactable pharmacist. A 26-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685; Expiration date was not reported), intramuscularly on the left arm on 11Jan2021 (10:45) at a single dose for COVID-19 immunization at the hospital. Medical history included hypothyroidism and allergy to sulfa drugs. The patient's concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EJ1685; Expiration date was not reported), intramuscularly on the left arm on 21Dec2020 (when the patient was 26 years old) for COVID-19 immunization. On 12Jan2021 (02:00), the patient had fevers, chills and body aches. The patient had received an unspecified over-the-counter (OTC) pain reliever and an unspecified ointment as treatment for the reported events. The outcome of the events, 'fevers', 'chills' and 'body aches', was unknown. The patient was not diagnosed with COVID-19 prior to the vaccination, and had not been tested post-vaccination.

Other Meds:

Current Illness:

ID: 0973399
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fast heartbeat/episode of rapid heartbeat; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on an unspecified date at single dose Covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient experienced fast heartbeat/episode of rapid heartbeat after the second dose on an unspecified date. The outcome of event was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 0973400
Sex: F
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blurred vision; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 12Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on an unspecified date for COVID-19 immunization. On 13Jan2021, the patient had blurred vision. The patient was going to an eye doctor on the day of reporting (reported as today at 1:00 PM). The outcome of the event, blurred vision, was unknown. Information on Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0973401
Sex: F
Age:
State: OR

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A swollen armpit; Arm hurts; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient's daughter) reported that a 39-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), via an unspecified route of administration in right arm on 08Jan2021 at a single dose for COVID-19 immunization. The patient has no medical history. There were no concomitant medications. The patient's arm hurts on 08Jan2021 and developed a swollen armpit on 10Jan2021. The outcome of swollen armpit was not recovered while arm hurts recovered on 10Jan2021.

Other Meds:

Current Illness:

ID: 0973402
Sex: F
Age:
State: AZ

Vax Date: 12/28/2020
Onset Date: 01/04/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: neck was mildly swollen/mild superficial neck swelling; bounding pulse (palpitations); bounding pulse (palpitations); This is a spontaneous report from a contactable consumer on behalf of herself. A 48-year-old female patient received her first BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EH9899, via an unspecified route of administration on 28Dec2020 at SINGLE DOSE at left upper arm for COVID-19 immunisation. There were no relevant medical histories or concomitant medications. The patient had a vaccination on 28Dec2020 and seven days later on 04Jan2021 her neck was mildly swollen and that same day it became more swollen and she had a bounding pulse also reported that had mild superficial neck swelling and a bounding pulse in her neck. The swelling has gone down, but got worse in the evening. The bounding pulse (palpitations) in her neck has improved but got worst at night, still occurred at night. No difficulty breathing and/or swallowing. She went to her physician on 05Jan2021 to find out why occurring. She was called to see if based off this symptom if she should have her second shot of vaccination. Followed up with her MD and had an Ultrasound (US) of her jugular in Jan2021 and all was normal. The outcome of the events was resolving.

Other Meds:

Current Illness:

ID: 0973403
Sex: F
Age:
State: VA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: aches and pain in hips; very lethargic/lethargy was worse; sore throat; chills; head pain/headaches; nauseous; had no appetite; had horrible diarrhea; stomach cramps; slept 13 hours which my normal is max 8 hours/Slept 15 hours straight Sun. To Mon; This is a spontaneous report received from a contactable consumer (patient). An adult female patient of an unspecified age (reported as 63, no unit provided, pending clarification) received the first dose of BNT162B2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284, expiry date: unknown), via an unspecified route of administration in right arm, on 08Jan2021 12:30, at single dose, for COVID-19 immunization, in the hospital. Medical history included known allergies to penicillin and mango. Concomitant medication included probiotics, colecalciferol (D3), cyanocobalamin (B12), lysine and elderberry (ELDERBERRY [SAMBUCUS NIGRA]). The patient did not receive other vaccines in 4 weeks. The patient did not have COVID-19 prior to vaccination. The patient is not pregnant. The patient received her first vaccine on 08Jan2021, Friday. On 09Jan2021 at 16:30, Saturday or next day after the vaccine, the patient got nauseous late in the afternoon and had no appetite, so she ate some Jasmine rice and Peppermint tea. Within 3 hours, she had horrible diarrhea and stomach cramps. She went to bed early and slept for 13 hours which her normal is max 8 hours. She woke up on 10Jan2021, Sunday, and was very lethargic and had sore throat, chills and head pain across the back of her head, she never had headaches. She slept for 15 hours straight from Sunday To Monday (10Jan2021-11Jan2021). She woke up with the same symptoms on 11Jan2021, Monday (same as Sunday), but lethargy was worse. She had the same diet & care on Sunday, Monday and Tuesday (10Jan2021-12Jan2021) hot tea and hot showers letting hot water beat on her head and body. The patient still had chills, sore throat, head pain and was lethargic. On 21Jan2021 (Tuesday evening by 19:30), head pain was gone, was not as lethargic & throat was not as sore. The patient only drank hot peppermint tea, 3 liters warm lemon filtered water and soup. The patient was gargling with warm salt water & took 800 mg MOTRIN daily. On 13Jan2021 (Wednesday, the patient was back at work Wednesday but started to experience aches and pain in hips and sore throat but better. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovered with sequelae (reported as recovered with lasting effects).

Other Meds: PROBIOTICS; D3; B12 [CYANOCOBALAMIN]; LYSINE; ELDERBERRY [SAMBUCUS NIGRA]

Current Illness:

ID: 0973404
Sex: F
Age:
State: MO

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever to 102.8; This is a spontaneous report from a contactable (patient). This 32-year-old female received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on 18Dec2020 at single dose for COVID-19 immunisation. The patient was vaccinated at Pharmacy or Drug Store. Age at vaccination was 32-years-old. No other vaccine was received in four weeks. Medical history and concomitant medications were unknown. About 20 hours after the first vaccine (Dec2020), the patient ran a fever to 102.8, lasted about 12 hours. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0973405
Sex: F
Age:
State: NC

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Disequilibrium, very mild; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249), via an unspecified route of administration in the right arm on 13Jan2021 08:30 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced disequilibrium, very mild on 13Jan2021 09:00. No treatment was received for the event. Outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 0973406
Sex: F
Age:
State: CA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: really big sharp headache; lots of vowel movements (Diarrhea); Chills; dizziness; This is a spontaneous report from a contactable healthcare professional. A 38-year-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular (right arm, second dose) from 12Jan2021 17:00 to 12Jan2021 17:00 at a single dose for COVID-19 vaccination. Medical history included UTI. Concomitant medication included sulfamethoxazole, trimethoprim (BACTRIM). Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Dec2020 (first dose). It was reported by the patient that she was awaken in the middle of the night because of a really big sharp headache also with lots of bowel movements (Diarrhea). The patient also had Chills and dizziness; all on 13Jan2021. There was no treatment for the events. The outcome of the events was not recovered. Information on the Lot/batch number has been requested.

Other Meds: BACTRIM

Current Illness:

ID: 0973407
Sex: F
Age:
State: IN

Vax Date: 01/04/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: nausea; sore throat/ throat hurt; feeling unwell; fatigue/extra tired; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EI1686; expiry date: unknown) intramuscular in the right arm, on 04Jan2021 at 12:00 at a single dose, for COVID-19 immunization. Medical history included diabetic/ diabetes diagnosed in 2015, high blood pressure, and high cholesterol, all prior vaccination. The patient has no relevant family history. The patient has no concomitant medications. Patient has no previous immunization with the Pfizer vaccine. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient received the first shot of the vaccine 04Jan2021 at 12:00, and she started feeling unwell during the weekend (Saturday; 09Jan2021). She's still experiencing these symptoms: fatigue, nausea, sore throat, and she's feeling worse. She called the COVID hotline because she was having fatigue and nausea. They told her to call her PCP and call Pfizer to report. After first dose on 04Jan2021, she felt ok over the weekend. She was just fatigued last night and had nausea and her throat hurts. She wanted to know about getting her second shot that is scheduled for 26Jan2021, if it is recommended or not. There was no prescriber. She received the vaccine through work clinic. She was extra tired this weekend, so Saturday would have been the start for that. She went to bed early and that was when the nausea started. It woke her up. Her throat hurt off and on through winter. But last night, it was worse than it has been. It comes and goes without any medication or anything. She was sure it was given in the muscle. NO emergency room (ER) or physician's office required. She called COVID hotline and they are making her go to the doctor before she can return to work. She has not gone yet. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0973408
Sex: F
Age:
State: MI

Vax Date: 01/04/2021
Onset Date: 01/06/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives; Itchiness; This is a spontaneous report from a contactable nurse. A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), via an unspecified route of administration from 04Jan2021 to 04Jan2021 at a single dose for COVID-19 immunization. Medical history included ongoing prediabetic and hyperlipidemia. Concomitant medication included metformin for prediabetic and pravastatin for hyperlipidemia; both ongoing. The nurse reports that the patient developed hives and itchiness 48 hours after the administration of the first dose. The patient received Benadryl and it is getting better with Benadryl. The outcome of the events was recovering.

Other Meds: METFORMIN; PRAVASTATIN

Current Illness: Prediabetes

ID: 0973409
Sex: F
Age:
State: PA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; headache; injection site soreness; This is a spontaneous report from a contactable other health care professional. A 36-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL0140), via an unspecified route of administration on 12Jan2021 16:00 at SINGLE DOSE at left arm for COVID-19 immunization. Medical history included Idiopathic intracranial hypertension. On 12Jan2021 20:00, the patient experienced Fatigue, Headache, Injection site soreness. The patient did not receive treatment for the events. The outcome of the events was recovering.

Other Meds:

Current Illness:

ID: 0973410
Sex: F
Age:
State: TX

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fever (up to 101.8?F ); Headache; Nausea; Fatigue; Body Aches; Swollen lymph nodes; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiry date not reported), via an unspecified route of administration in the left arm on 07Jan2021 08:00 at single dose for COVID-19 immunisation. Medical history was not reported. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included ibuprofen (ADVIL), paracetamol (TYLENOL), calcium carbonate (TUMS), citalopram and birth control (unspecified medication). The patient previously took first dose of bnt162b2 (lot number: EJ1685, expiry date not reported), via an unspecified route of administration in the left arm on 20Dec2020 11:00 at single dose for COVID-19 immunisation. On 07Jan2021 18:30, the patient experienced chills, fever (up to 101.8?F), headache, nausea, fatigue, body aches and swollen lymph nodes. The patient underwent lab tests and procedures which included aars-cov-2 test: negative on 08Jan2021 COVID test result=Negative. No treatment was received for the adverse events. Clinical outcome of the events recovered on an unspecified date.

Other Meds: Advil; Tylenol; Tums; Citalopram.

Current Illness:

ID: 0973411
Sex: F
Age:
State: VA

Vax Date: 12/17/2020
Onset Date: 12/23/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen lymph nodes around left clavicle and close to armpit and neck, that happened 5 days after the first dose of COVID vaccine and they are very painful; Swollen lymph nodes around left clavicle and close to armpit and neck; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration in left arm on 17Dec2020 08:00 at single dose for COVID-19 immunization. Medical history included migraine from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took oxycodone and experienced allergy. The patient was not pregnant. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 23Dec2020 07:00 PM, the patient experienced swollen lymph nodes around left clavicle and close to armpit and neck, that happened 5 days after the first dose of COVID vaccine and they are very painful. The outcome of the events was recovering. No treatment was given to the patient for the events.

Other Meds:

Current Illness:

ID: 0973412
Sex: U
Age:
State: GA

Vax Date: 12/23/2020
Onset Date: 12/24/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; Fatigue; This is a spontaneous report from a contactable healthcare professional (patient). A 36-year-old patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm, on 23Dec2020 at 17:45, at a single dose, for COVID-19 immunization. The patient had no medical history. The patient's concomitant medications were not reported. The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. On 24Dec2020 at 6 AM, the patient experienced fever, chills, and fatigue lasting 36 hours. No treatment was received for the events. Post vaccination on an unspecified date, the patient underwent COVID-19 nasal swab test that was negative. The patient recovered from the events on 25Dec2020 (18:00).

Other Meds:

Current Illness:

ID: 0973413
Sex: M
Age:
State:

Vax Date: 12/28/2020
Onset Date: 01/03/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 6 days after the first dose he received a diagnostic with a positive test for COVID-19; 6 days after the first dose he received a diagnostic with a positive test for COVID-19; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient called that he was administered with the first dose of Pfizer's COVID-19 vaccine on 28Dec2020 and 6 days after (03Jan2021) the first dose, he received a positive result for a COVID-19 laboratory test. He started with symptoms of COVID-19 between 4 to 6 days after the administration of the vaccine and he had scheduled the second dose of the vaccine in 2 days (at the time of report). He had been quarantined appropriately after being diagnosed. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973414
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I developed a rash at the injection site after my second dose (both of which were given in my left arm), which made me wonder if I should have alternated injection sites.; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration on an unspecified date at a SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient asked if it would it be beneficial to recommend that the two doses of the Covid vaccine be given in different arms for each patient. On an unspecified date, the patient developed a rash at the injection site after the second dose (both of which were given in the left arm), which made the patient wonder if she should have alternated injection sites. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0973415
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: ringing in both of my ears got worse started slightly after the first dose and gotten worse after the second dose; ringing in both of my ears got worse started slightly after the first dose and gotten worse after the second dose; This is a spontaneous report from a non-contactable nurse. A 32-year-old male patient receive d BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose , via an unspecified route of administration to Jan2021 at SINGLE DOSE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. On an unknown date, the patient experienced ringing in both of ears got worse started slightly after the first dose and gotten worse after the second dose. Patient stated that it kind off went away toward right before the second dose, was ok for a day or two 5th or 6th getting worse again. Patient stopped two of her meds that could cause this. The vaccine was the only thing that has changed. The second dose was administered on unknown date in Jan2021 (5th or 6th of Jan2021). The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 0973416
Sex: M
Age:
State: NE

Vax Date: 01/04/2021
Onset Date: 01/05/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; mild soreness/arm sore/soreness in the arm; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on 04Jan2021 15:00 at a SINGLE DOSE for covid-19 immunisation, naproxen sodium (ALEVE), via an unspecified route of administration on 04Jan2021 at an unspecified dose and frequency for an unspecified indication. Medical history included blood pressure abnormal, blood uric acid abnormal, hypersensitivity, blood cholesterol abnormal, all from an unknown date and unknown if ongoing. Concomitant medication included alopurinol (ALOPURINOL), 300mg take once daily by mouth for Uric acid, amlodipine besilate (AMLODIPINE BESILATE) 10mg; take once daily by mouth for blood pressure, atorvastatin calcium (ATORVASTATIN CALCIUM) 20mg; take one half daily by mouth for cholesterol, cetirizine (CETIRIZINE) 10mg take once daily as needed for allergy, omeprazole (OMEPRAZOLE) 20mg; take one twice daily by mouth for uric acid, losartan (LOSARTAN), 100mg; take once daily by mouth for Blood pressure. The patient called regarding the Pfizer COVID 19 vaccine. He received his first dose of the vaccine at the a Hospital. He added he had just taken Aleve before the vaccination. Then he was reading in his heart magazine and it said it could effect the efficacy of the shot if you take aspirin or ibuprofen. He was asking for more information about that and was it okay that he took Aleve. He clarified he received the first dose of the Pfizer COVID 19 vaccine on 04Jan2021 at 15:00 PM in the left arm. He took the Aleve at 08:00 04Jan2021. He reports he had no pain the first day, no soreness in the arm or anything. The next day he had mild soreness in arm like the flu or pneumonia shot. On the third day he was a little fatigued. But by the fourth day he was able to take his usual walk of three or four miles without being winded and he was fine. He was planning for the second dose 25Jan2021 at 15:00. The outcome of the event pain in extremity was recovered on 06Jan2021 and the event fatigue was recovered on 07Jan2021.

Other Meds: ALOPURINOL; AMLODIPINE BESILATE; ATORVASTATIN CALCIUM; CETIRIZINE; OMEPRAZOLE; LOSARTAN

Current Illness:

ID: 0973417
Sex: F
Age:
State: KS

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Fevers; minor body aches/severe body aches; small headache/severe headaches; This is a spontaneous report from a contactable nurse (patient). A 33-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231), via an unspecified route of administration in the left arm on 12Jan2021 10:30 at a single dose for COVID-19 immunization. The patient's medical history included sub clinical hyperthyroidism and diagnosed with COVID prior to vaccination. The patient had no known allergies to medications, food, or other products. The patient was not pregnant. Concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), in the left arm on 21Dec2020 11:45 for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and any other medications within 2 weeks of vaccination. On 12Jan2021 20:00, the patient experienced minor body aches and a small headache. She went to bed and woke up at approx. 13Jan2021 00:15 with severe body aches, severe headaches, chills, and fevers. Therapeutic measures were taken as a result of the adverse events and included treatment with ibuprofen and diphenhydramine (BENADRYL). Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0973418
Sex: F
Age:
State: FL

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Throwing up, violently; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283), via an unspecified route of administration in right arm on 12Jan2021 11:30 AM at for COVID-19 immunization. Medical history included breast cancer, heart valve problem, asthma, and allergies. The patient's concomitant medications were not reported. The patient experienced throwing up, violently on 12Jan2021 11:30 AM. Patient dose not have COVID prior vaccination. Patient was not tested for COVID post vaccination. No treatment was received for the adverse event. The outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 0973419
Sex: F
Age:
State:

Vax Date: 01/09/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Low grade fever; Very tired; Arm pain; This is a spontaneous report from a non-contactable consumer (patient). A adult female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 09Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 19Dec2020 for COVID-19 immunization. On 09Jan2021, the patient had low grade fever; was very tired; and had arm pain. The patient had not received any treatment for the reported events. The outcome of the events, 'low grade fever', 'very tired' and 'arm pain', was recovered in Jan2021. The patient was not diagnosed with COVID-19 prior to the vaccination, and it was unknown if she had been tested post-vaccination. No follow-up attempts are possible. Information about Lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0973420
Sex: F
Age:
State: MD

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a flood of heat throughout my body; pain in my calf muscle; tingling; Woke me up all night; super dizzy; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3302), via an unspecified route of administration in the left arm on 12Jan2021 10:00 at a single dose for COVID-19 immunization. There were no medical history. The patient is not pregnant. Concomitant medication included amoxicillin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. The patient experienced super dizzy on 12Jan2021 10:06, a flood of heat throughout her body, pain in her calf muscle, tingling, and it woke her up all night on 12Jan2021 12:00. Outcome of the events was recovering.

Other Meds: Amoxicillin

Current Illness:

ID: 0973421
Sex: M
Age:
State:

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Bone aches; Minor HA; Diarrhea; Violent vomiting; A jaundice color of skin; This is a spontaneous report from a non-contactable pharmacist. A 55-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL3246), intramuscular on 12Jan2021 at a single dose for COVID-19 immunization in a hospital. The patient's medical history and concomitant medications were not reported. On 12Jan2021, the evening after the vaccine was administered, the patient experienced chills, bone aches, and minor HA that then worsened to explosive diarrhea and violent vomiting with a jaundice color of skin. The events resulted in a doctor or other healthcare professional office/clinic visit. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0973422
Sex: F
Age:
State: LA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: menstrual cycle started 4 days early with heavier than usual flow; Myalgias; Chills; Tmax 100.7; This is a spontaneous report from a contactable physician reported for herself. A 41-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL0142), intramuscular in the right arm on 08Jan2021, 15:00 at a single dose for covid-19 immunisation. The patient's medical history was not reported. The patient did not have Covid prior to vaccination. Patient did not have other vaccine in four weeks. Concomitant medications included multivitamin. The patient previously took amoxicillin and experienced hypersensitivity (reported as known allergies to amoxicillin). The patient received the first dose of bnt162b2 (lot:EK5730), intramuscularly in the right arm on 18Dec2020 at 11:00AM at a single dose for covid-19 immunization. The patient experienced myalgias, chills, tmax 100.7 on 09Jan2021 09:00. It was also reported that patient's menstrual cycle started 4 days early with heavier than usual flow on 09Jan2021 11:00. Patient did not received treatment for the events. The outcome of the event myalgia, chills and pyrexia, was recovered on 09Jan2021, 21:00 and recovered on an unknown date for the event menstrual cycle abnormal. Patient was not tested positive for Covid-19 post vaccination.

Other Meds: MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 0973423
Sex: F
Age:
State: VA

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen and tender left neck lymph node; Swollen and tender left neck lymph node; Headache; Tiredness; This is a spontaneous report from a contactable other health professional (HCP). A 35-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), intramuscular on left arm, on 12Jan2021 at 09:15, at a single dose for COVID-19 immunization. Medical history included anxiety and migraine from an unknown date and unknown if ongoing. Concomitant medication included escitalopram. The patient received the first dose of BNT162B2 (lot number: EH9899), intramuscularly on left arm at 23Dec2020, 03:30 PM. The patient experienced swollen and tender left neck lymph node, headache and tiredness; all on 12Jan2021 at 17:30. There was no treatment given for the events. The outcome of the events was not recovered.

Other Meds: Escitalopram

Current Illness:

ID: 0973424
Sex: F
Age:
State: NC

Vax Date: 12/28/2020
Onset Date: 01/03/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; a little tired; second dose was due 25Jan2021; Tested positive for COVID-19 on 03Jan2021/congestion and cough; Tested positive for COVID-19 on 03Jan2021/congestion and cough; This is a spontaneous report from a contactable nurse via a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). This 39-year-old female nurse (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via intramuscular at left deltoid on 28Dec2020 11am at single dose for COVID-19 immunization. Medical history included non-smoker with no other illness. Concomitant medication was none. The patient had not been treated with immunomodulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. Patient reported after receiving her first dose of the COVID-19 vaccine on 28Dec2020, she had sore arm and a little tired, other than that felt fine. She stated second dose was due 25Jan2021. She was tested positive for COVID-19 (Rapid Covid testing) on 03Jan2021. She already decided going to wait the 90-day-period to get the second dose of the vaccine. Since she was quarantined she wanted to what she should do. She stated her having testing positive for Covid did not have anything to do with the vaccine. She still had some lingering symptoms, congestion and cough. Nothing had worsened, but just wouldn't go away. She did not receive any other vaccines the same day or 4 weeks prior. No history of problems with vaccines in past. She had not had antibodies checked yet. It was reported no AE required a visit to emergency room/physician office. The patient was not hospitalized. The patient received no additional therapies for COVID-19. Patient's outcome with COVID-19 was recovering, and the rest of events was unknown.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported tested positive for COVID-19 (Rapid Covid testing), which is considered ineffective of BNT162B2, and the administration of BNT162B2.

Other Meds:

Current Illness:

ID: 0973425
Sex: F
Age:
State: FL

Vax Date: 12/18/2020
Onset Date: 12/19/2020
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild swelling and tenderness of corresponding vaccine site arm in armpit lymph nodes; mild swelling and tenderness of corresponding vaccine site arm in armpit lymph nodes; This is a spontaneous report from a contactable pharmacist. A 44-year-old female patient received bnt162b2 (BNT162B2), the first dose (lot number: EH9899, expiry date: not reported), intramuscularly, on 18Dec2020 04:00 PM, at a single dose, on the left arm; and the second dose (lot number: EL1284, expiry date: not reported), intramuscularly, on 07Jan2021 11: 00 AM, at a single dose, on the right arm, both for COVID-19 immunization. The vaccine was administered in a hospital. The patient was not pregnant. Medical history included COVID. It was reported that patient was diagnosed with COVID prior to vaccination and was not tested for COVID post vaccination. The patient had no known allergies. Concomitant medications included ethinylestradiol, levonorgestrel (JOLESSA), cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), ergocalciferol (VIT D); these are the other medications she received in two weeks. The patient did not receive any other vaccine within four weeks. The patient experienced mild swelling and tenderness of corresponding vaccine site arm in armpit lymph nodes the evening following both covid 19 vaccine doses 1 and 2. This lasted 48-72 hours and then resolved. The first dose was received on 18Dec2020 with reaction occurred on 19Dec2020. The second dose was received on 07Jan2021 with reaction occurred on 08Jan2021 06:00 PM (also reported as "09Jan2021"). The patient did not receive any treatment for the reported adverse events. Outcome of the events was recovered on an unspecified date.

Other Meds: JOLESSA; VITAMIN B12 [CYANOCOBALAMIN]; VIT D

Current Illness:

ID: 0973426
Sex: M
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Tiredness/Exhaustion; Chills; Low grade fever; Muscle aches; Weakness; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231; expiry date: unknown) via an unspecified route of administration, on an unspecified date in Jan2021 at 15:30, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received first dose of the Pfizer BioNTech Covid-19 vaccine on Monday at 3:30 P.M. He woke up yesterday morning with exhaustion, tiredness, chills, low grade fever, muscle aches, and just weakness that hasn't stopped since yesterday morning. All these lasted for 48 hours. Patient then asked how long he will experience these. Outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0973427
Sex: M
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbing on right side of face/numbness in my right arm; hard time swallowing; dizziness; fogginess; disorientation; hard of hearing; right ear felt very clogged; This is a spontaneous report from a contactable healthcare professional. A male patient of an unspecified age (reported as 43 with unspecified units) received his first dose of bnt162b2 (BNT162B2 reported as PFIZER-BIONTECH COVID-19 VACCINE and also reported as covid vaccine; unknown lot number and expiration date), via an unspecified route of administration on 11Jan2021 at a single dose for covid-19 immunization. The patient's concomitant medications and medical history were not reported. The patient reported that he received the covid vaccine on Monday late afternoon on 11Jan2021. He reported side effects of numbing on right side of face, hard time swallowing and numbness in his right arm on Jan2021. On Jan2021, he had initial symptoms of dizziness, fogginess and disorientation and then went to bed and woke up with additional symptoms (what he mentioned earlier). The patient added that his right ear felt very clogged and was hard of hearing at the time, but now it has resolved (that was the last thing that went away). The patient inquired if he should get the second dose. He mentioned that all the symptoms cleared up and he inquired as to what are the recommendation. The outcome of the events was recovered on Jan2021. The following information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 0973428
Sex: F
Age:
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red and blotchy spots to the arm of injection site; This is a spontaneous report from a contactable consumer. An 83-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: EL1283), via an unspecified route of administration on 13Jan2021 13:00 at SINGLE DOSE at arm right for COVID-19 immunization. Medical history included Chronic Lymphomatic Leukemia (CLL), and Heart attack in 2016. The patient's concomitant medications were not reported. The patient had the vaccine 4 hours ago and her whole arm down to the fingers is blotchy red as well as where the injection was given, it's her whole arm, just blotchy red dots. She received the First Dose at 1PM Eastern Time and probably about 2 and a half hours later is when the blotchiness appeared. The patient was experiencing red and blotchy spots to the arm of injection site. Redness and blotchy coloration appear to be under the skin down to her hand and wrist. She asks if this is a normal side effect. She has had no positive test for Covid Before the Vaccine. She has had No Antibody Tests. She has had No issues with vaccines in the past. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 0973429
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/26/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm swelled up and she had a lump; arm swelled up and she had a lump; This is a spontaneous report from a contactable Pharmacist. A female patient (age: 70s) received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced arm swelled up and she had a lump on an unspecified date with outcome of unknown. Information about Lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 279,999

Page last modified: 03 October 2021 5:28pm